1. Describe an "armed" oncolytic virus approach with potential to reprogram TME and counteract multiple immune resistance mechanisms.
2. How indoleamine 2,3 dioxygenase (IDO) represents a potent metabolic immune checkpoint beyond generation KYN.
05/12/2021 - 8:00am to 9:00am CDT
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Adekunle Odunsi, MD, PhD